Eleanor N Fish

InstitutionUniversity of Toronto
AddressToronto
Ontario
Canada
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 1 publications in May 2020 and October 2020 and November 2020 and December 2020 and August 2021
    All Publications
    Bar chart showing 105 publications over 20 distinct years, with a maximum of 11 publications in 2012
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Iturriaga C, Eiffler N, Aniba R, Ben-Othman R, Perez-Mateluna G, Meyer JKV, Fish EN, Kollmann TR, Severino N, Stick S, Borzutzky A, Perret C, Castro-Rodriguez JA, Garcia-Huidobro D. A cluster randomized trial of interferon ß-1a for the reduction of transmission of SARS-Cov-2: protocol for the Containing Coronavirus Disease 19 trial (ConCorD-19). BMC Infect Dis. 2021 Aug 13; 21(1):814. PMID: 34388972.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Zhou Q, MacArthur MR, He X, Wei X, Zarin P, Hanna BS, Wang ZH, Xiang X, Fish EN. Interferon-a2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities. Viruses. 2020 12 30; 13(1). PMID: 33396578.
      Citations: 9     Fields:    Translation:HumansCells
    3. Mazewski C, Perez RE, Fish EN, Platanias LC. Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways. Front Immunol. 2020; 11:606456. PMID: 33329603.
      Citations: 11     Fields:    Translation:HumansAnimalsCells
    4. Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Corrigendum: Interferon-a2b Treatment for COVID-19. Front Immunol. 2020; 11:615275. PMID: 33193462.
      Citations: 3     Fields:    
    5. Zhou Q, Chen V, Shannon CP, Wei XS, Xiang X, Wang X, Wang ZH, Tebbutt SJ, Kollmann TR, Fish EN. Interferon-a2b Treatment for COVID-19. Front Immunol. 2020; 11:1061. PMID: 32574262.
      Citations: 132     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    6. Wang BX, Fish EN. Global virus outbreaks: Interferons as 1st responders. Semin Immunol. 2019 06; 43:101300. PMID: 31771760.
      Citations: 44     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    7. Rogers E, Wang BX, Cui Z, Rowley DR, Ressler SJ, Vyakarnam A, Fish EN. WFDC1/ps20: a host factor that influences the neutrophil response to murine hepatitis virus (MHV) 1 infection. Antiviral Res. 2012 Nov; 96(2):158-68. PMID: 22960155.
      Citations: 3     Fields:    Translation:AnimalsCells
    8. Baig E, Fish EN. Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir Ther. 2008; 13(3):409-22. PMID: 18572754.
      Citations: 16     Fields:    Translation:AnimalsCells
    9. De Albuquerque N, Baig E, Ma X, Zhang J, He W, Rowe A, Habal M, Liu M, Shalev I, Downey GP, Gorczynski R, Butany J, Leibowitz J, Weiss SR, McGilvray ID, Phillips MJ, Fish EN, Levy GA. Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol. 2006 Nov; 80(21):10382-94. PMID: 17041219.
      Citations: 75     Fields:    Translation:HumansAnimalsCells
    10. Zorzitto J, Galligan CL, Ueng JJ, Fish EN. Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro. Cell Res. 2006 Feb; 16(2):220-9. PMID: 16474437.
      Citations: 23     Fields:    Translation:HumansAnimalsCells
    11. DeAlbuquerque N, Baig E, Xuezhong M, Shalev I, Phillips MJ, Habal M, Leibowitz J, McGilvray I, Butany J, Fish E, Levy G. Murine hepatitis virus strain 1 as a model for severe acute respiratory distress syndrome (SARS). Adv Exp Med Biol. 2006; 581:373-8. PMID: 17037562.
      Citations: 7     Fields:    Translation:AnimalsCells
    12. Ward SE, Loutfy MR, Blatt LM, Siminovitch KA, Chen J, Hinek A, Wolff B, Pham DH, Deif H, LaMere EA, Kain KC, Farcas GA, Ferguson P, Latchford M, Levy G, Fung L, Dennis JW, Lai EK, Fish EN. Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. Antivir Ther. 2005; 10(2):263-75. PMID: 15865221.
      Citations: 18     Fields:    Translation:Humans